- Home
- ZWS vs AXSM Comparison
ZWS vs AXSM Comparison
Compare ZWS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZWS
- AXSM
- Stock Information
- Founded
- ZWS 1891
- AXSM 2012
- Country
- ZWS United States
- AXSM United States
- Employees
- ZWS N/A
- AXSM N/A
- Industry
- ZWS Industrial Machinery/Components
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ZWS Industrials
- AXSM Health Care
- Exchange
- ZWS Nasdaq
- AXSM Nasdaq
- Market Cap
- ZWS 5.9B
- AXSM 5.1B
- IPO Year
- ZWS 2012
- AXSM 2015
- Fundamental
- Price
- ZWS $44.69
- AXSM $109.22
- Analyst Decision
- ZWS Buy
- AXSM Strong Buy
- Analyst Count
- ZWS 5
- AXSM 16
- Target Price
- ZWS $40.00
- AXSM $176.56
- AVG Volume (30 Days)
- ZWS 1.4M
- AXSM 626.4K
- Earning Date
- ZWS 07-29-2025
- AXSM 08-04-2025
- Dividend Yield
- ZWS 0.81%
- AXSM N/A
- EPS Growth
- ZWS 30.58
- AXSM N/A
- EPS
- ZWS 1.01
- AXSM N/A
- Revenue
- ZWS $1,614,000,000.00
- AXSM $495,033,000.00
- Revenue This Year
- ZWS $4.31
- AXSM $61.62
- Revenue Next Year
- ZWS $4.65
- AXSM $59.02
- P/E Ratio
- ZWS $45.16
- AXSM N/A
- Revenue Growth
- ZWS 4.74
- AXSM 69.83
- 52 Week Low
- ZWS $27.74
- AXSM $75.56
- 52 Week High
- ZWS $45.90
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- ZWS 67.54
- AXSM 58.17
- Support Level
- ZWS $43.80
- AXSM $102.67
- Resistance Level
- ZWS $45.90
- AXSM $110.34
- Average True Range (ATR)
- ZWS 1.15
- AXSM 3.77
- MACD
- ZWS 0.11
- AXSM 0.74
- Stochastic Oscillator
- ZWS 84.87
- AXSM 92.11
About ZWS Zurn Elkay Water Solutions Corporation
Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.